The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway

Biochemical Pharmacology

Volumn 84, Issue 9, 2012, Pages 1143-1153

  Chen, Hui Jye ^a   Hsu, Le Shiang ^b   Shia, Yu Ting ^a   Lin, Meng Wei ^a   Lin, Chung Ming ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b MING CHUAN UNIVERSITY   (Taiwan)

Author keywords

Catenin; Colorectal cancer; Resveratrol; TCF; Wnt

Indexed keywords

BETA CATENIN; CYCLIN D1; RESVERATROL; T CELL FACTOR PROTEIN; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL NUCLEUS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DRUG PROTEIN BINDING; GENE EXPRESSION; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; PRIORITY JOURNAL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PROTEIN BINDING; SIGNAL TRANSDUCTION; STILBENES; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 84866599883     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.08.011     Document Type: Article

References (46)

1. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
2. G.V. De Ferrari, and R.T. Moon The ups and downs of Wnt signaling in prevalent neurological disorders Oncogene 25 2006 7545 7553
3. M.L. Johnson, and N. Rajamannan Diseases of Wnt signaling Rev Endocr Metab Disord 7 2006 41 49
4. R.T. Moon, A.D. Kohn, G.V. De Ferrari, and A. Kaykas WNT and beta-catenin signalling: diseases and therapies Nat Rev Genet 5 2004 691 701
5. J. Luo, J. Chen, Z.L. Deng, X. Luo, W.X. Song, and K.A. Sharff Wnt signaling and human diseases: what are the therapeutic implications Lab Invest 87 2007 97 103
6. F. Verkaar, and G.J. Zaman New avenues to target Wnt/beta-catenin signaling Drug Discov Today 16 2011 35 41
7. H.J. Chen, C.M. Lin, C.S. Lin, R. Perez-Olle, C.L. Leung, and R.K. Liem The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway Genes Dev 20 2006 1933 1945
8. B.T. MacDonald, K. Tamai, and X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev Cell 17 2009 9 26
9. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
10. S.D. Markowitz, and M.M. Bertagnolli Molecular origins of cancer: molecular basis of colorectal cancer N Engl J Med 361 2009 2449 2460
11. A.J. Rowan, H. Lamlum, M. Ilyas, J. Wheeler, J. Straub, and A. Papadopoulou APC mutations in sporadic colorectal tumors: a mutational hotspot and interdependence of the two hits Proc Natl Acad Sci USA 97 2000 3352 3357
12. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
13. P. Polakis Wnt signaling and cancer Genes Dev 14 2000 1837 1851
14. P.J. Morin, A.B. Sparks, V. Korinek, N. Barker, H. Clevers, and B. Vogelstein Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275 1997 1787 1790
15. Y. Shukla, and R. Singh Resveratrol and cellular mechanisms of cancer prevention Ann N Y Acad Sci 1215 2011 1 8
16. W. Yu, Y.C. Fu, and W. Wang Cellular and molecular effects of resveratrol in health and disease J Cell Biochem 113 2012 752 759
17. A.M. Roccaro, X. Leleu, A. Sacco, A.S. Moreau, E. Hatjiharissi, and X. Jia Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia Clin Cancer Res 14 2008 1849 1858
18. Y.C. Liang, S.H. Tsai, L. Chen, S.Y. Lin-Shiau, and J.K. Lin Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells Biochem Pharmacol 65 2003 1053 1060
19. H. Fujie, K. Moriya, Y. Shintani, T. Tsutsumi, T. Takayama, and M. Makuuchi Frequent beta-catenin aberration in human hepatocellular carcinoma Hepatol Res 20 2001 39 51
20. D.K. Woo, H.S. Kim, H.S. Lee, Y.H. Kang, H.K. Yang, and W.H. Kim Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines Int J Cancer 95 2001 108 113
21. P.J. Morin beta-catenin signaling and cancer Bioessays 21 1999 1021 1030
22. P. Polakis The oncogenic activation of beta-catenin Curr Opin Genet Dev 9 1999 15 21
23. M.E. Juan, M.P. Vinardell, and J.M. Planas The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful J Nutr 132 2002 257 260
24. T.C. Hsieh, and J.M. Wu Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines Exp Cell Res 249 1999 109 115
25. A.K. Joe, H. Liu, M. Suzui, M.E. Vural, D. Xiao, and I.B. Weinstein Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin Cancer Res 8 2002 893 903
26. F. Wolter, B. Akoglu, A. Clausnitzer, and J. Stein Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines J Nutr 131 2001 2197 2203
27. X. Gao, Y.X. Xu, G. Divine, N. Janakiraman, R.A. Chapman, and S.C. Gautam Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes J Nutr 132 2002 2076 2081
28. L. Tessitore, A. Davit, I. Sarotto, and G. Caderni Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression Carcinogenesis 21 2000 1619 1622
29. S. Shankar, I. Siddiqui, and R.K. Srivastava Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells Mol Cell Biochem 304 2007 273 285
30. C. Hope, K. Planutis, M. Planutiene, M.P. Moyer, K.S. Johal, and J. Woo Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention Mol Nutr Food Res 52 Suppl 1 2008 S52 S61
31. H. Zhou, L. Shang, X. Li, X. Zhang, G. Gao, and C. Guo Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells Exp Cell Res 315 2009 2953 2962
32. H. Wang, H. Zhou, Y. Zou, Q. Liu, C. Guo, and G. Gao Resveratrol modulates angiogenesis through the GSK3beta/beta-catenin/TCF-dependent pathway in human endothelial cells Biochem Pharmacol 80 2010 1386 1395
33. S.M. Huang, Y.M. Mishina, S. Liu, A. Cheung, F. Stegmeier, and G.A. Michaud Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Nature 461 2009 614 620
34. B. Chen, M.E. Dodge, W. Tang, J. Lu, Z. Ma, and C.W. Fan Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer Nat Chem Biol 5 2009 100 107
35. Y. Kawasaki, R. Sato, and T. Akiyama Mutated APC and Asef are involved in the migration of colorectal tumour cells Nat Cell Biol 5 2003 211 215
36. N.R. Rodrigues, A. Rowan, M.E. Smith, I.B. Kerr, W.F. Bodmer, and J.V. Gannon p53 mutations in colorectal cancer Proc Natl Acad Sci USA 87 1990 7555 7559
37. J.P. Medema, and L. Vermeulen Microenvironmental regulation of stem cells in intestinal homeostasis and cancer Nature 474 2011 318 326
38. A.G. Vaiopoulos, I.D. Kostakis, M. Koutsilieris, and A.G. Papavassiliou Colorectal cancer stem cells Stem Cells 30 2012 363 371
39. A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, and G. Sette Chemotherapy resistance of glioblastoma stem cells Cell Death Differ 13 2006 1238 1241
40. Y. Saiki, S. Ishimaru, K. Mimori, Y. Takatsuno, M. Nagahara, and H. Ishii Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells Ann Surg Oncol 16 2009 2638 2644
41. C.W. Ong, L.G. Kim, H.H. Kong, L.Y. Low, B. Iacopetta, and R. Soong CD133 expression predicts for non-response to chemotherapy in colorectal cancer Mod Pathol 23 2010 450 457
42. S. Saigusa, K. Tanaka, Y. Toiyama, T. Yokoe, Y. Okugawa, and Y. Ioue Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy Ann Surg Oncol 16 2009 3488 3498
43. R. Nusse, C. Fuerer, W. Ching, K. Harnish, C. Logan, and A. Zeng Wnt signaling and stem cell control Cold Spring Harb Symp Quant Biol 73 2008 59 66
44. T. Reya, and H. Clevers Wnt signalling in stem cells and cancer Nature 434 2005 843 850
45. L. Vermeulen, E.M.F. De Sousa, M. van der Heijden, K. Cameron, J.H. de Jong, and T. Borovski Wnt activity defines colon cancer stem cells and is regulated by the microenvironment Nat Cell Biol 12 2010 468 476
46. Y. Wang, A.V. Krivtsov, A.U. Sinha, T.E. North, W. Goessling, and Z. Feng The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML Science 327 2010 1650 1653